Self-Assembling Peptides: How They're Designed and Used in Medicine

Self-assembling peptides form a diverse range of micro- and nanostructures — including nanofibers, hydrogels, and nanotubes — that serve as platforms for tissue regeneration and drug delivery. By modifying amino acid composition, researchers can mimic biological functions, load both hydrophobic and hydrophilic drugs, and engineer stimuli-responsive release at targeted disease sites. The review highlights that biocompatibility and molecular recognition targeting are among their most significant advantages over conventional delivery systems.

This is a literature review summarizing recent and significant studies on self-assembled peptide nanostructures, with emphasis on biomedical applications including drug delivery systems and tissue engineering scaffolds.

Drug delivery remains one of the biggest challenges in medicine — getting the right amount of a drug to exactly where it's needed without side effects. Self-assembling peptides represent a promising platform that could improve how drugs are delivered, make tissue regeneration more effective, and ultimately lead to better patient outcomes.

Self-assembling peptides sit at the intersection of nanotechnology, materials science, and biomedicine. As the field advances, these designer molecules could become standard tools for creating drug delivery vehicles that are more precise, biocompatible, and effective than current options — potentially transforming treatment for cancer, infections, and degenerative diseases.

As a review article, this does not present original experimental data. The field of self-assembling peptides evolves rapidly, so some methods discussed may have been superseded. The review primarily focuses on laboratory-stage research, and many of the described applications have not yet reached clinical trials in humans.